Arctic Fuji, a genetically modified non-browning apple variety developed by Okanagan Specialty Fruits (OSF), has been approved by the US Department of Agriculture's Animal and Plant Health Inspection Service (USDA APHIS). OSF, which is a ...
Tags: Arctic Fuji, OSF, USDA APHIS
American biotechnology company Intrexon has completed the acquisition of Okanagan Specialty Fruits (OSF), the agricultural company behind the world's first non-browning apple, Arctic apple. British Columbia based OSF developed the ...
OvaScience, a life sciences company, and Intrexon Corporation have announced an agreement to access Intrexon’s portfolio of technologies to accelerate the development of OvaScience’s OvaTure technology platform Separately, ...
Tags: OvaScience, Infertility Treatments
Sears Holdings Corporation announced the election of Cesar L. Alvarez, co-chairman of the international law firm of Greenberg Traurig, LLP, to membership on the Sears Holdings board of directors. "I am delighted that Cesar is joining our ...
Tags: Sears Holdings
Synthetic Biologics and Intrexon have commenced development of a monoclonal antibody (mAb) therapy, SYN-005, to treat pertussis, commonly known as whooping cough. To manage the rising number of pertussis cases, Synthetic Biologics intends ...
Tags: Synthetic Biologics, monoclonal antibody therapy, whooping cough
Synthetic Biologics has enterd into second worldwide exclusive channel collaboration with Intrexon to address unmet medical needs of infectious diseases. Synthetic Biologics leverages Intrexon's suite of proprietary technologies for the ...
Tags: Synthetic Biologics, infectious diseases, medical needs